Start Date: 09/01/2017

End Date: 14/01/2017

Cost: Free

Venue: Wellcome Genome Campus Conference Centre, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1RQ, United Kingdom

Organiser:

Wellcome Genome Campus Advanced Courses and Scientific Conferences

Contact Details:

The programme will focus on several disorders including Alzheimer’s disease, Parkinson’s disease, Fragile X, Spinocerebellar ataxia and amyotrophic lateral sclerosis. There are many parallels between different neurodegenerative disorders and the course will examine the common themes across neurodegenerative processes. Participants will gain an insight into the current understanding of both rare and common neurological disorders, the strengths and weaknesses of experimental approaches and evidence, and how this knowledge can be applied to develop therapies.

The programme is aimed at individuals working in neurodegenerative research, neurogenetics or translational neuroscience, including clinician scientists, veterinary scientists, PhD students and post-doctoral researchers. We encourage applications from researchers based in the pharmaceutical and biotechnology industries. Applications from those who have completed a PhD in another area and have moved into neuroscience for their postdoctoral studies will also be considered.

The course will benefit researchers who seek a comprehensive view of neurodegenerative disorders together with state of the art research techniques, and who wish to gain a new perspective on their own studies. The intensive programme provides the opportunity to interact with leading international neuroscientists. To optimize discussions and interactions, numbers are limited to 30 students.

The programme is lecture-based but highly interactive. Participants will have the opportunity to share their research with tutors, speakers and other students throughout the course, during the formal poster sessions and discussion sessions. 

Topics will include:
Pathological events in neurodegeneration
Autophagy, aging and neurodegeneration
Genetic variation in inherited and sporadic disease
Use of in vivo models to study neurological pathogenesis
Modelling neurodegeneration using iPSCs
Development of therapeutic approaches

Link: go.evvnt.com/60293-0